Highlights from the second iteration of the PRiME COVID-19 mini symposium established to showcase research recently funded by the Toronto COVID-19 Action Fund. This post features research being done to improve the throughput of SARS-CoV-2 testing, to develop robust antibody testing and therapeutics, and the facilities that support this expanding field.

Highlights from the first iteration of the PRiME COVID-19 mini symposium established to showcase research recently funded by the Toronto COVID-19 Action Fund. Funded projects include the development of core facilities and open access resources, and research on novel antiviral drug targets, identification of host dependency factors, and the advancement of diagnostic and serological tests.